Skip to main content
SpringerLink
Log in

Macrophage Migration Inhibitory Factor And Hypothalamo-Pituitary-Adrenal Function During Critical Illness

  • Conference paper
Advances in Critical Care Testing

Abstract

Macrophage migration inhibitory factor (MIF) is a multifunctional mediator with pituitary hormone, pro-inFlammatory cytokine and catalytic enzyme activities1. MIF has the capacity to override the anti-inFlammatory and immunosuppressive actions of glucocorticoids (GCs)2. MIF production is induced by low concentrations of GCs, but also by cytokines and stress activation. We evaluated the intriguing role of MIF in the complex network of immuno-neuroendocrine adaptation3 during critical illness, by measuring blood levels of MIF and its relation with the HPA-axis, the acute phase response, cytokines, the severity of illness and ICU mortality.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Swope MD, Lolis E. MIF: cytokine, hormone or enzyme? Rev Physiol Biochem Pharmacol 1999;139:1–32

    Article  PubMed  CAS  Google Scholar 

  2. Calandra T, Bernhagen J, Metz CN et al. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995; 377:68–71

    Article  PubMed  CAS  Google Scholar 

  3. Beishuizen A. Immuno-neuro-endocrine adaptation in critical illness. Thesis. Vrije Universiteit 2001, Amsterdam

    Google Scholar 

References

  1. Metz CN, Bucala R. 1997 Role of macrophage migration inhibitory factor in the regulation of the immune response. Adv Immunol. 66:197–223.

    Article  PubMed  CAS  Google Scholar 

  2. Swope MD, Lolis E. 1999 Macrophage migration inhibitory factor: cytokine, hormone, or enzyme? Rev Physiol Biochem Pharmacol. 139:1–32.

    Article  PubMed  CAS  Google Scholar 

  3. Bernhagen J, Calandra T, Bucala R. 1994 The emerging role of MIF in septic shock and infection. Biotherapy. 8:123–127.

    Article  PubMed  CAS  Google Scholar 

  4. Calandra T, Spiegel LA, Metz CN, Bucala R. 1998 Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria. Proc Natl Acad Sci USA. 95:11383–11388.

    Article  PubMed  CAS  Google Scholar 

  5. Calandra T, Bucala R. 1997 Macrophage migration inhibitory factor (MIF): a glucocorticoid counter-regulator within the immune system. Crit Rev Immunol. 17:77–88.

    Article  PubMed  CAS  Google Scholar 

  6. Donnelly SC, Bucala R. 1997 Macrophage migration inhibitory factor: a regulator of glucocorticoid activity with a critical role in inFlammatory disease. Mol Med Today. 3:502–507.

    Article  PubMed  CAS  Google Scholar 

  7. Calandra T, Bernhagen J, Metz CN, et al. 1995 MIF as a glucocorticoidinduced modulator of cytokine production. Nature. 377:68–71.

    Article  PubMed  CAS  Google Scholar 

  8. Morand EF, Leech M. 1999 Glucocorticoid regulation of inFlammation: the plot thickens. InFlamm Res. 48:557–560.

    Article  PubMed  CAS  Google Scholar 

  9. Bernhagen J, Calandra T, Mitchell RA, et al. 1993 MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature. 365:756–759.

    Article  PubMed  CAS  Google Scholar 

  10. Calandra T, Bernhagen J, Mitchell RA, Bucala R. 1994 The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med. 179:1895–1902.

    Article  PubMed  CAS  Google Scholar 

  11. Calandra T, Bucala R. 1995 Macrophage migration inhibitory factor: a counterregulator of glucocorticoid action and critical mediator of septic shock. J InFlamm. 47:39–51.

    PubMed  CAS  Google Scholar 

  12. Nishino T, Bernhagen J, Shiiki H, Calandra T, Dohi K, Bucala R. 1995 Localization of macrophage migration inhibitory factor (MIF) to secretory granules within the corticotrophic and thyrotrophic cells of the pituitary gland. Mol Med. 1:781–788.

    PubMed  CAS  Google Scholar 

  13. Bacher M, Meinhardt A, Lan HY, et al. 1997 Migration inhibitory factor expression in experimentally induced endotoxemia. Am J Pathol. 150:235–246.

    PubMed  CAS  Google Scholar 

  14. Vermes I, Beishuizen A, Hampsink RM, Haanen C. 1995 Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: possible role of endothelin and atrial natriuretic hormone. J Clin Endocrinol Metab. 80:1238–1242.

    Article  PubMed  CAS  Google Scholar 

  15. Van den Berghe G, De Zegher F, Bouillon R. 1998 Acute and prolonged critical illness as different neuroendocrine paradigms. J Clin Endocrinol Metab.83:1827–1834.

    Article  PubMed  Google Scholar 

  16. Bucala R. 1996 MIF rediscovered: cytokine, pituitary hormone, and glucocorticoid-induced regulator of the immune response. FASEB J. 10:1607–1613.

    PubMed  CAS  Google Scholar 

  17. Bernhagen J, Calandra T, Bucala R. 1998 Regulation of the immune response by macrophage migration inhibitory factor: biological and structural features. J Mol Med. 76:151–161.

    Article  PubMed  CAS  Google Scholar 

  18. Bernhagen J, Bacher M, Calandra T, et al. 1996 An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction. J Exp Med. 183:277–282.

    Article  PubMed  CAS  Google Scholar 

  19. Lan HY, Bacher M, Yang N, et al. 1997 The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat. J Exp Med. 185:1455–1465.

    Article  PubMed  CAS  Google Scholar 

  20. Onodera S, Suzuki K, Matsuno T, Kaneda K, Takagi M, Nishihira J. 1997 Macrophage migration inhibitory factor induces phagocytosis of foreign particles by macrophages in autocrine and paracrine fashion. Immunology. 92:131–137.

    Article  PubMed  CAS  Google Scholar 

  21. Xu D, McSorley SJ, Tetley L, et al. 1998 Protective effect on Leishmania major infection of migration inhibitory factor, TNF-a, and IFN-gadministered orally via attenuated Salmonella typhimurium. J Immunol. 160:1285–1289.

    CAS  Google Scholar 

  22. Steinhoff M, Meinhardt A, Steinhoff A, Gemsa D, Bucala R, Bacher M. 1999 Evidence for a role of macrophage migration inhibitory factor in psoriatic skin disease. Br J Dermatol. 141: 1061–1066.

    Article  PubMed  CAS  Google Scholar 

  23. Leech M, Metz C, Hall P, et al. 1999 Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinFlammatory function and regulation by glucocorticoids. Arthritis Rheum. 42:1601–1608.

    Article  PubMed  CAS  Google Scholar 

  24. Chesney J, Metz C, Bacher M, Peng T, Meinhardt A, Bucala R. 1999 An ssential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma. Mol Med. 5:181–191.

    PubMed  CAS  Google Scholar 

  25. Martiney JA, Sherry B, Metz CN, et al. 2000 Macrophage migration inhibitory factor release by macrophages after ingestion of Plasmodium chabaudi-infected erythrocytes: possible role in the pathogenesis of malarial anemia. Infect Immun. 68:2259–2267.

    Article  PubMed  CAS  Google Scholar 

  26. Bozza M, Satoskar AR, Lin G, et al. 1999 Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J Exp Med. 189:341–346.

    Article  PubMed  CAS  Google Scholar 

  27. Calandra T, Echtenacher B, Roy DL, et al. 2000 Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med. 6:164–170.

    Article  PubMed  CAS  Google Scholar 

  28. Bone RC, Sibbald WJ, Sprung CL. 1992 The ACCP-SCCM consensus conference on sepsis and organ failure. Chest. 101:1481–3.

    Article  PubMed  CAS  Google Scholar 

  29. Baker SP, O’Neill B, Haddon Jr W, Long WB. 1974 The injury severity score: MIF AND HPA FUNCTION IN CRITICAL ILLNESS 2815 a method for describing patients with multiple injuries and evaluating emergency care. J Trauma. 14:187–196.

    Article  PubMed  CAS  Google Scholar 

  30. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. 1985 APACHE II: a everity of disease classification system. Crit Care Med. 13:818–829.

    Article  PubMed  CAS  Google Scholar 

  31. Vincent JL, Moreno R, Takala J, et al. 1996 The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. Intensive Care Med. 22:707–710.

    Article  PubMed  CAS  Google Scholar 

  32. Bernard GR, Artigas A, Brigham KL, et al. 1994 The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 149:818–824.

    PubMed  CAS  Google Scholar 

  33. Malmegrin KCR, Beishuizen A, Sluijs Veer van der GJ, Vermes I. 2000 Time-resolved fluorometric immunoassay of macrophage migration inhibitory factor. J Clin Ligand Assay. 20:74–80.

    Google Scholar 

  34. Beishuizen A, Vermes I, Haanen C. 2000 Hypotension, hypovolemia, and septic shock. In: Fink G, ed. Encyclopedia of stress, 1st Ed. New York: Academic Press; 460–468.

    Google Scholar 

  35. Naito Y, Fukata J, Tamai S, et al. 1991 Biphasic changes in hypothalamopituitary-adrenal function during the early recovery period after major abdominal surgery. J Clin Endocrinol Metab. 73:111–117.

    Article  PubMed  CAS  Google Scholar 

  36. Bethin KE, Vogt SK, Muglia LJ. 2000 Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation. Proc Natl Acad Sci USA. 97:9317–9322.

    Article  PubMed  CAS  Google Scholar 

  37. Chrousos GP. 1995 The hypothalamic-pituitary-adrenal axis and immunemediated inFlammation. N Engl J Med. 332:1351–1362.

    Article  PubMed  CAS  Google Scholar 

  38. Besedovsky HO, Del Rey A. 1996 Immune-neuro-endocrine interactions: facts and hypotheses. Endocr Rev. 17:64–102.

    PubMed  CAS  Google Scholar 

  39. Braithwaite SS. 1998 Procalcitonin-marker, or mediator? Crit Care Med. 26:977–978.

    Article  PubMed  CAS  Google Scholar 

  40. Whang KT, Vath SD, Nylen ES, et al. 1999 Procalcitonin and proinFlammatory cytokine in interactions in sepsis. Shock. 12:268–273.

    Article  PubMed  CAS  Google Scholar 

  41. Berczi I.1998 Neurohormonal host defense in endotoxin shock. Ann NY Acad Sci. 840:787–802.

    Google Scholar 

  42. Lamping N, Dettmer R, Schroder NW, et al. 1998 LPS-binding protein protects mice from septic shock caused by LPS or Gram-negative bacteria. J Clin Invest. 101:2065–2071.

    Article  PubMed  CAS  Google Scholar 

  43. Opal SM, Scannon PJ, Vincent JL, et al. 1999 Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Dis. 180:1584–1589.

    Article  PubMed  CAS  Google Scholar 

  44. Bacher M, Metz CN, Calandra T, et al. 1996 An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci USA. 93:7849–7854.

    Article  PubMed  CAS  Google Scholar 

  45. Kleemann R, Hausser A, Geiger G, et al. 2000 Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jabl. Nature. 408:211–216.

    Article  PubMed  CAS  Google Scholar 

  46. Dorshkind K, Horseman ND. 2000 The roles of prolactin, growth hormone, insulin-like growth factor-1, and thyroid hormones in lymphocyte development and function: insights from genetic models of hormone and hormone receptor deficiency. Endocr Rev. 21:292–312.

    Article  PubMed  CAS  Google Scholar 

  47. Stocklin E, Wissler M, Gouilleux F, Groner B. 1996 Functional interactions between Stat5 and the glucocorticoid receptor. Nature. 383:726–728.

    Article  PubMed  CAS  Google Scholar 

  48. Daun JM, Cannon JG. 2000 Macrophage migration inhibitory factor antagonizes hydrocortisone-induced increases in cytosolic IkBa. Am J Physiol Regul Integr Comp Physiol. 279:R1043–R1049.

    PubMed  CAS  Google Scholar 

  49. Donnelly SC, Haslett C, Reid PT, et al. 1997 Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med. 3:320–323.

    Article  PubMed  CAS  Google Scholar 

  50. Makita H, Nishimura M, Miyamoto K, et al. 1998 Effect of anti-macrophage migration inhibitory factor antibody on lipopolysaccharide-induced pulmonary neutrophil accumulation. Am J Respir Crit Care Med. 158:573–579.

    PubMed  CAS  Google Scholar 

  51. Martin TR. 2000 MIF mediation of sepsis. Nat Med. 6:140–141.

    Article  PubMed  CAS  Google Scholar 

  52. Matot I, Sprung CL. 1998 Corticosteroids in septic shock: resurrection of the last rites? Crit Care Med. 26:627–630.

    Article  PubMed  CAS  Google Scholar 

  53. Meduri GU, Kanangat S. 1998 Glucocorticoid treatment of sepsis and acute respiratory distress syndrome: time for a critical reappraisal. Crit Care Med. 26:630–633.

    Article  PubMed  CAS  Google Scholar 

  54. Beishuizen A, Vermes I, Hylkema BS, Haanen C. 1999 Relative eosinophilia and functional adrenal insufficiency in critically ill patients. Lancet. 353:1675–1676.

    Article  PubMed  CAS  Google Scholar 

  55. Beishuizen A, Vermes I. 1999 Relative eosinophilia (Thorn test) as a bioassay to judge the clinical relevance of cortisol values during severe stress. J Clin Endocrinol Metab. 84:3400.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Internal Medicine, Medical Spectrum Twente, Hospital Group, Enschede, Netherlands

    A. Beishuizen

  2. Clinical Chemistry, Medical Spectrum Twente, Hospital Group, Enschede, Netherlands

    C. Haanen & I. N. Vermes

  3. Medical Intensive Care Unit, Free University Hospital, Amsterdam, Netherlands

    A. Beishuizen & L. J. Thijs

Authors
  1. A. Beishuizen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. J. Thijs
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Haanen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. I. N. Vermes
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Health Services Division, Oak Ridge National Laboratory, Oak Ridge, TN, 37831-6220, USA

    Carl A. Burtis

  2. Institute of Laboratory Diagnostics, Kaiser Franz Josef Hospital, Kundratstrasse 3, 1100, Vienna, Austria

    Mathias M. Müller

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Beishuizen, A., Thijs, L.J., Haanen, C., Vermes, I.N. (2004). Macrophage Migration Inhibitory Factor And Hypothalamo-Pituitary-Adrenal Function During Critical Illness. In: Burtis, C.A., Müller, M.M. (eds) Advances in Critical Care Testing. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18480-2_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-18480-2_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-40752-2

  • Online ISBN: 978-3-642-18480-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation